[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.

@article{Minutoli2006186ReHEDPIT,
  title={[186Re]HEDP in the palliation of painful bone metastases from cancers other than prostate and breast.},
  author={Fabio Minutoli and Astrid Herberg and P Spadaro and G Restifo Pecorella and Demetrio Aric{\`o} and G. Altavilla and Sara Baldari},
  journal={The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...},
  year={2006},
  volume={50 4},
  pages={355-62}
}
AIM Palliative therapy using [186Re]hydroxyethylidene diphosphonate (HEDP) has been widely tested in patients with bone metastases from prostate and breast cancers. Whereas, to the best of our knowledge, only few cases of bone metastases from tumors other than prostate and breast treated with [186Re]HEDP have been reported. The aim of this paper is to report our experience with 186Re-HEDP in the palliation of painful bone metastases from tumors other than prostate and breast. METHODS In this… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-6 of 6 extracted citations

Radiochemical studies, pre-clinical investigation and preliminary clinical evaluation of 170Tm-EDTMP prepared using in-house freeze-dried EDTMP kit.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine • 2017
View 2 Excerpts

Similar Papers

Loading similar papers…